Introduction
Carbon nanotubes (CNT) are receiving ever-increasing attention due to their unique structural characteristics offering high strength to weight ratios, improved conductivity and thermal stability e.g. CNT fillers in polymers result in CNT/polymer composites with significantly improved thermal or electrical conductivity compared to the polymer alone [1, 2] .
Typically occurring with diameters in the 10 -100 nm range and with lengths often extending much greater than 1 μ m, CNTs are being applied in areas such as electronics, automotive, aerospace and medical industries [3] . The application of these materials to consumer products is certain to expand significantly and the risk of exposure to humans is therefore also set to significantly increase. Human exposure to CNTs may occur at the initial synthesis stage of the material, during the industrial application and incorporation of the material into products and subsequently throughout the life cycle of the CNT composite material/products. The biological reactivity of CNTs is likely to depend on their physicochemical properties, including their structure (single-walled or multi-walled; SWCNT or MWCNT respectively), their length, diameter, surface charge, aggregative state and synthesis catalyst impurities.
The inhalation of some engineered nanomaterials, such as MWCNTs, is potentially a significant human health concern. Evidence for this from existing studies shows the adverse effects of inhaled air pollution particles (which contains an ultrafine component that is analogous in size to engineered nanomaterials) on the cardiopulmonary system [4] . A large portion of inhaled nanosized particles deposit in the alveolar unit [5] where the active gas-blood interface has a tightjunctional cellular barrier composed of type-I (ATI) and type-II (ATII) epithelial cells abutting the capillary endothelial cells for effective gas exchange. Although there are approximately equal numbers of ATI and ATII cells within the alveolar unit, the thin, attenuated ATI epithelial cells cover 95% of the alveolar surface [6] . Cuboidal ATII cells synthesise, secrete and recycle surfactant, modulate both fluid balance and host defense and can terminally differentiate into ATI cells, where gas exchange occurs by diffusion. Resident alveolar macrophages (AM) police the airspaces, removing inhaled particles, pathogens and cellular debris.
In early MWCNT studies by Shvedova et al (mouse pharyngeal aspiration exposure to SWCNTs) and Muller et al (rat intratracheal instillation exposure to MWCNTs), MWCNTs were found to persist in the lung for up to 60 days post exposure, elicit dose-dependent increases in lung cell inflammation, stimulate oxidative stress markers in lung tissue and induce early onset of lung fibrosis [7, 8] . Significantly, the biopersistent, fibrous nature of MWCNTs renders them somewhat comparable to the well-studied lung toxicant, asbestos. Evidence suggests that long, thin, needle-like and biopersistent fibers (e.g. amphibole asbestos) are involved in the development of pulmonary mesothelioma (an incurable cancer largely due to asbestos exposure), while both long and short asbestos fibers contribute to fibrosis and the development of asbestosis (a chronic inflammatory and fibrotic pathology) [9] . mesothelial cells [10] [11] [12] . While these studies highlight MWCNT length as a potential determinant of pulmonary toxicity, significant challenges in precisely synthesising MWCNTs, so that just one physicochemical property is changed while all others remain identical, make it difficult to determine the role of a single, specific physicochemical property in bioreactivity of
MWCNTs.
Furthermore, while the ever-expanding research effort into MWCNT pulmonary toxicity is beginning to reveal some important mechanisms by which these materials may induce cellular bioreactivity in the lung (recently reviewed by Donaldson et al [13] ), there is a paucity of experimental data using primary human lung cells. This is a critical knowledge gap, as it is well known, for example, that cellular processes and mediators differ between species and thus the relevance of some in vitro screening studies, which utilize non-human material and cell lines, is unclear. There is therefore a crucial need for more studies of relevant human pulmonary cell models. Additionally, human ATI epithelial cells remain very poorly studied, despite their significant relevance in nanomaterial deposition in the respiratory units after inhalation of nanosized materials. Therefore, in this study, we chose to study the bioreactivity of MWCNT length using highly relevant primary human ATII and AMs (from the same subjects) and human alveolar type-I-like epithelial cell line (TT1) generated in-house [14] . We hypothesized that three thoroughly-characterised MWCNTs formats (each with a different length but, importantly, maintaining a comparable diameter, surface charge and carbon purity i.e. % atomic carbon) would exhibit adverse effects on primary human alveolar epithelium and alveolar macrophages, such that the long MWCNTs, with similar lengths to those of amphibole asbestos implicated in the development of mesothelioma, would exert the most deleterious response, whilst shorter MWCNTs would be less bioreactive.
Experimental

Physicochemical characterisation of carbon nanotubes
Non-functionalised, MWCNTs (synthesised by chemical vapor deposition), denoted MWCNT-0.6μ m, MWCNT-3μ m and MWCNT-20μ m, were purchased from Nanothinx, Greece.
MWCNT surface charge (as zeta potential) was determined by zeta-meter using a Zetasizer Nano by Malvern Instruments (Worcestershire, UK). All MWCNT samples were suspended in deionised water and DCCM-1 culture medium to determine any alteration of physiochemical characteristics. The respective length and diameter distribution of each MWCNT sample was determined by transmission electron microscopy using a Hitachi 7100 TEM, while the respective agglomerative state of each MWCNT format was determined by scanning electron microscopy using a Carl Zeiss Ultra Plus Field emission SEM. The suspension stability was estimated by zeta potential measurements, using Malvern ZetaSizer Nano. Elemental mapping, to determine the nature and degree of MWCNT impurities, was also performed using a Carl Zeiss Ultra Plus Field emission SEM in energy-dispersive mode for X-ray spectroscopy (EDX). All three MWCNT samples were assayed for endotoxin contamination, using a Pierce LAL Chromogenic Endotoxin Quantitation Kit (Thermo Scientific, UK) and all three were below the 0.1 EU/mL limit of detection. BET surface area measurements were performed on Beckman Coulter SA3100 (Beckman Coulter Inc., USA).
Ethics Statement
The human lung tissue used in this study was surplus tissue obtained following resection for lung carcinoma. Written informed consent was obtained for all samples and the study was carried out with the approval of the Royal Brompton and Harefield Ethical Committee (Ref:
08/H0708/73).
Cell models
Primary human ATII cells and AMs were isolated from human lung of grossly normal appearance obtained following resection for lung carcinoma, as described by Thorley et al [15] .
Cells were isolated from a minimum of three subjects per experiment, with a total of fifteen subjects used in this study. Briefly, lung tissue sections were perfused by injection of 0.15 M sterile sodium chloride saline solution until the draining lavage ran clear and the cell count was < 1x10 4 cells/ml. The saline perfusate was collected and centrifuged at 1300rpm for 10 minutes at 20oC. The cell pellet was re-suspended in serum-free RPMI cell culture medium containing 1% penicillin/streptomycin/L-glutamine (PSG) and plated on 96 well culture plates at 0.2 x10 6 AMs/well. After AM adherence (approximately three hours), culture medium was removed and non-adherent cells were removed by phosphate buffered saline (PBS) washing. AM cultures were then maintained in serum-free RPMI cell culture medium containing 1% PSG.
The tissue was then prepared for ATII cell isolation by perfusing with trypsin (0.25% in Hanks balanced salt solution) and incubating at 37 o C for 45 minutes; trypsin was replaced twice during the incubation period. The tissue was then finely chopped in the presence of newborn calf serum (NCS), shaken for five minutes with DNase (250 μ g/ml) at room temperature and passed through a 400μ m filter followed by a 40 μ m filter to remove large tissue debris. The cell-containing filtrate was then centrifuged at 1300 rpm for 10 minutes and the resulting pellet was re-suspended in DCCM-1 culture medium containing 50 μ g/ml DNase. Cells were then incubated in tissue culture flasks for two hours (humidified incubator, 5% CO 2 /95% air at 37°C) to allow differential adherence and removal of contaminating mononuclear cells. Non-adherent ATII cells were removed after 2 hours and the cell suspension was centrifuged at 1300 rpm for 10 minutes. The resulting pellet was re-suspended in a DCCM-1 culture medium containing 10%NCS and 1%
PSG and cells were seeded on 96 well culture plates at 0.1 x10 6 cells/well. The 96 well culture plates were previously coated with 50 μ l of 1% PureCol collagen solution (Leimuiden, Netherlands; Type I collagen) and allowed to air dry. Cells reached confluence after 48 hours.
These cells have been thoroughly characterised using electron microscopy, which shows that the cells are cuboidal in morphology, have surfactant-containing lamellar bodies, tight junctions and microvilli. Furthermore they stain positively for the ATII cell marker alkaline phosphatase and express surfactant proteins A and C and maintain their phenotype for up to six days [16, 17] .
This laboratory has previously immortalised human ATI-like cells (derived from freshly isolated and cultured primary human ATII cells) using transduction with the catalytic subunit of telomerase (human telomerase reverse transcriptase; hTERT) and a temperature sensitive mutant of simian virus 40 large-tumour antigen [14] . These ATI-like (transformed type-I-like; TT1) cells, the first human ATI-like cell line to be produced, are negative for the ATII cell markers SP-C, alkaline phosphatase and thyroid transcription factor-1. Moreover, TT1s do not contain lamellar bodies. They display a thin, attenuated morphology containing vesicles, being caveolae positive. TT1 cells were cultured to confluence in 96-well culture plates using DCCM-1 tissue culture medium with 10 % FCS new-born calf serum, 0.05% G418 and 10% PSG. An initial cell seeding of 0.1 x 10 6 /well yielded a confluent monolayer after 48 hours. Growth medium was replaced with serum-free DCCM-1 24 hours prior to MWCNT exposure. Cells were incubated in humidified 5% CO 2 /95% air at 37°C. TT1 and ATII cells possess the ability to spread and divide, unlike AMs. Consequently, the final cell numbers in confluent TT1 and ATII monolayers could not be determined from the initial number of seeded cells. Similarly, some of the plated AMs may not adhere. Such a potential discrepancy in seeded and actual final cell numbers, when significant, would influence the determination cytokine and chemokine activity when comparing responses between cell types.
Confluent monolayers of each cell type were therefore imaged under light microscope (100X magnification) and counted manually. We determined that final TT1, ATII and AM cell numbers per well were comparable (data not shown).
Treatment of TT1 cells, ATII cells and AMs with MWCNTs
Respective MWCNT format doses were prepared in fresh serum-free DCCM-1 or RPMI culture medium for subsequent TT1 cell, ATII and AM exposure. It was favorable to freshly prepare the MWCNT doses immediately prior to cell exposure. Each MWCNT dose preparation was sonicated in a sonicating water bath (135W, 42 kHz; VWR) for 30 seconds prior to cell culture exposure.
Choice of dose metric
The choice of dose metric in nanomaterial toxicology studies (e.g. particle mass, particle number, particle surface area) is a contentious issue [18] [19] [20] [21] . While we appreciate that there are relative merits to each of these, we have chosen to present our data with a mass dose metric, using a wide concentration range; this facilitates a useful comparison of our study with similar in vitro studies evaluating MWCNT length in cellular reactivity and where mass is used as a dose metric (e.g. [12, 22, 23] ).
Measurement of cell viability
The effect of each of the three MWCNT formats on AM, TT1 and ATII cell viability, at MTT and LDH assays were repeated in triplicate using three separate TT1 cell passages and matched ATII cells and AMs from four subjects. We have established that the MWCNTs used in this study do not interfere with the solubilisation of formazan and therefore do not interfere with the MTT cell viability assay (data not shown).
Measurement of cytokines and chemokines by ELISA
Exposures were repeated in triplicate using three separate TT1 cell passages and ATII cells and AMs from four subjects. Mediator-conditioned medium from MWCNT-exposed TT1 cell, ATII cell and AM cultures was assayed for concentrations of inflammatory cytokines (human IL-6) and inflammatory chemokines (human IL-8 and MCP-1) using sandwich enzymelinked immunosorbent assays (ELISA). The assays were performed using DuoSet ® antibody kits.
The manufacturer's directions (R&D systems, USA) were followed.
Inhibition of the MAP kinases JNK, p38 and ERK 1/2 in TT1 cells, ATII cells and AMs
To Western blot analysis confirmed successful inhibition of respective MAP kinases in all three cell types (data not shown). shown in Table 1 . 
Statistical Analysis
Results and Discussion
Physicochemical properties of selected carbon nanotubes
Cell viability
The effect of MWCNT length on TT1, ATII and AM cell viability (from 0.1 to 100 μ g/ml) was assessed over a 24-hour exposure period (Figure 4 ; viability was also assessed at 4 hours, however no significant changes were observed; data not shown). Because certain MWCNTs have been shown to interfere in some cell viability assays [24] , we performed two experimentally distinct assays (MTT and LDH assays) to validate our cell viability conclusions.
In the MTT assay, TT1 cell viability remained unchanged up to 10 μ g/ml, regardless of MWCNT length ( Figure 4A ). Small but significant decreases in TT1 cell viability (up to 20%) did occur at higher MWCNT doses (50 and 100 μ g/ml), however these doses are unlikely to be physiologically relevant to human health. As with TT1 cells, ATII cell viability remained unchanged for all MWCNT format exposures at low doses that are more likely to be physiologically relevant (up to 10 μ g/ml; Figure 4A that MWCNTs pierce the membranes of human macrophages [26] ; this may be one mechanism for the MWCNT-induced AM cell death seen in the present study. The reduction in AM viability in response to shorter MWCNT formats (MWCNT-0.6μ m and MWCNT-3μ m), while still significant at doses from 10 to 100 μ g/ml, and relatively greater than that seen in epithelial cells, was significantly less than (~15%) responses seen following exposure to the longer MWCNTs.
Using the LDH release cytotoxicity assay, the trend in the degree of damage and reduction in cell viability reflected that observed in the MTT assay, where short MWCNTs caused more LDH release from epithelial cells and long MWCNTs caused most release from AMs ( Figure 4B ).
However, the magnitude of cytotoxicity as measured by LDH release was less than that measured using the MTT assay. For example, an MTT-determined 38% reduction in AM cell viability following treatment with 50 μ g/ml of MWCNT-20μ m, measured as a 22% reduction when the LDH release assay was used for the same treatment. Nevertheless, the agreement between these two distinct assays, in terms of the trend in cell viability reduction, verifies our cell viability observations. 
Inflammatory cytokine and chemokine release
Based on cell viability data, a dose range of 0 -50 μ g/ml was chosen for inflammatory mediator release studies. Following 24-hour treatment (inflammatory mediators were also assessed at 4 hours treatment, however no significant changes were observed; data not shown) we found that differential responses to MWCNT lengths were critically dependent on the cell type being exposed. The TT1 and ATII epithelial cells were significantly more responsive to the μ g/ml) were sufficient to evoke significant increases in interleukin-6 (IL-6) and IL-8 release from treated ATII cells e.g. more than a two-fold increase in IL-8 release following MWCNT-0.6μ m treatment at these low doses. TT1 and ATII monocyte chemoattractant protein-1 (MCP-1) release was also increased; again, the greatest increases were seen following treatment with the shortest MWCNTs ( Figure 5 ); at very low doses, where there were striking increases in MCP-1 release by both TT1 and ATII cells. IL-8 and MCP-1 are proinflammatory chemokines, functioning in neutrophil and monocyte attraction to sites of cellular inflammation. Notably, increased release of IL-6 (a pleiotropic cytokine important in inflammation) is associated with the pathogenesis of numerous lung diseases such as asthma [27] , chronic obstructive pulmonary disease [28] and idiopathic pulmonary fibrosis [29] . IL-6 has been shown to readily translocate from the lung to systemic circulation upon exposure to particulate matter [30] and it is also a robust predictor of cardiovascular disease in humans [31] . Therefore, the finding of a concentration-dependent increase in IL-6 release by TT1 and ATII cells is significant. Thus, in the present study we have shown that inhalation of very small amounts of short MWCNT and deposition in the respiratory units, would be would be very likely to induce inflammation within the human alveolar unit, even in the absence of cell death.
In [23] . Previous studies by us have shown that primary human AMs (and indeed primary human ATII cells and TT1 cells) abundantly express TLRs including TLR-2 and TLR-4 [32, 33] . Considering this, and the well-established downstream TLR signaling connection with MAP kinases [34] (which were activated in the present study; discussed below), these extracellular receptors are potentially important for both short and long MWCNT interactions with alveolar epithelial cells and AMs.
The phenomenon of differential MWCNT activity, based on length, has also been described by Liu et al [35] . In their study, they showed that treatment of RAW264.7 murine macrophages with [22] . Here, the authors found that shortened MWCNTs (~5μ m in length; produced by sonicating MWCNTs of ~10μ m in length) had increased surface oxygen and were more bioreactive than their parent MWCNTs.
We also acknowledge that increased oxygen content may play some part in MWCNT bioreactivity. However, in the present study, while we did observe a small difference in oxygen content between the parent and shortened MWCNTs, the atomic percent variation on oxygen content was below 10% for all MWCNTs and unlikely to contribute, particularly since the short (9% oxygen) were most bioreactive with epithelial cells, whilst long (~4% oxygen) were most bioreactive with AMs, indicating that oxygen is unlikely to be a driving factor (Figure 3 ).
Considering this, it is much more likely that MWCNT length is the critical determinant in human lung cell bioreactivity. The observations in the present study are also important as they highlight that the use of single cell type in vitro models, often employed in other studies and in industrial safety assessments, may not be sufficient to understand the risk of MWCNTs on human pulmonary health. For example, the alveolar epithelial cell study alone would deceptively indicate that long MWCNTs are not as important in bioreactivity within the human alveolar unit.
Yet, our finding that treating human AMs with short MWCNTs had a lesser effect on mediator release when compared with long MWCNTs, suggests that particle length is an important regulatory factor in human AM activation. Similarly, the AM study alone would mislead us into thinking that induced MCP-1 release, and consequential monocyte recruitment, is not important; however this conclusion would neglect the substantial amount of MCP-1 produced by the intimately neighbouring alveolar epithelial cells following MWCNT treatment. Figure 5 . Inflammatory mediator release from TT1 and ATII epithelial cells and AMs following treatment with MWCNTs for 24 hours. Release of IL-6, IL-8 and MCP-1 from MWCNTexposed (1-50 μ g/ml) TT1, ATII cells and AMs. Mediator release is presented as pg/ml; significant differences are indicated where * P < 0.05, ** P < 0.01 and *** P < 0.001.
Role of MAP kinase signalling in MWCNT bioreactivity with TT1 and ATII cells and AMs
To further investigate the cellular processes leading to pro-inflammatory mediator release from TT1 and ATII epithelial cells and AMs upon exposure to MWCNTs of different lengths, we studied the potential involvement of MAP kinase signalling. Specific inhibition of JNK, p38
and ERK 1/2, prior to MWCNT treatment, was achieved using 10 μ M of each respective inhibitor (as previously optimised by Thorley et al [33] ). Their effect on pro-inflammatory mediator release was then measured following treatment with each of the MWCNT formats (a 50μ g/ml dose was chosen as it typically induced the greatest magnitude of mediator release, thus it would give us the best chance of seeing any effects of the MAP kinase inhibitors on reducing mediator release).
SP600125 is a cell-permeable, selective inhibitor of JNK phosphorylation [36] , SB203580 inhibits p38 catalytic activity but does not inhibit the phosphorylation of p38 by upstream kinases [37] and PD98059 binds to the inactive forms of ERK 1/2, preventing activation by upstream activators [38] . In TT1 and ATII epithelial cells, inhibition of MAP kinases significantly reduced the magnitude of the cytokine and chemokine response to MWCNTs there was no effect on AM MCP-1 release, again in contrast to the epithelial cell responses, likely reflecting the lack of impact of these MWCNTs on AM MCP-1 release. The role of MAP kinases in MWCNT bioreactivity with lung cells has been studied by others, with variable conclusions across other species. For example, Hirano et al showed that MWCNTs (10 -100 μ g/ml) did not activate ERK 1/2, JNK or p38 in J774.1 mouse monocyte macrophages [25] . It is possible that the biointeraction of MWCNTs with mouse blood monocytes is different to that with human alveolar macrophages, thus we see contrasting observations in the present study. 
Conclusion
Exposure to MWCNTs through inhalation could activate the pulmonary alveolar epithelium and alveolar macrophages, resulting in a pro-inflammatory response and possibly longer term, chronic pathology, depending on the exposure load. We studied the effect of wellcharacterised MWCNTs using highly relevant and primary human lung cell models, to address the hypothesis that increased aspect ratio would be a critical determinant of any cytotoxicity and bioreactivity. We used three MWCNT formats with different lengths (MWCNT-0.6μ m, MWCNT-3μ m and MWCNT-20μ m), but comparable diameters (~30nm), surface charges (negative) and carbon purities (~92%). We have shown that all three MWCNTs caused adverse effects, where bioreactivity depended on MWCNT length. Unexpectedly, and in contrast to our original hypothesis, the severity of the effect also depended on the cell type exposed. Shorter
MWCNTs were more reactive with the TT1 and ATII epithelial cells, even at very low concentrations, for all inflammatory mediators. However, long MWCNTs had virtually no effect on IL-6 and IL-8 release from the epithelial cells, and a reduced effect on MCP-1 release. In direct contrast, the longer MWCNTs were more reactive with the AMs, causing significant cell death and stimulating significant increases in IL-6 and IL-8. Nevertheless, the shorter MWCNTs did induce AM IL-6 and IL-8 release, however this was relatively lower and decreased in relation to decreasing MWCNT length. The inability of MWCNTs to induce MCP-1 release by
AMs is also interesting. The pro-inflammatory effect of these MWCNT formats was found to correspond to MAP kinase signalling, the relative role differing according to cell type and mediator released. Our discovery that the short MWCNTs induce the greatest responses from alveolar epithelial cells, without significant cell death, opens up a number of possibilities, that, following inhalation of short MWCNTs, these cells (particularly ATII cells, which release higher levels of mediators under the same experimental conditions) might orchestrate the inflammatory response and subsequent interstitial/cardiovascular events.
MWCNTs of different lengths have numerous commercial applications and can therefore all be considered a potential respiratory hazard. This unique study, comparing responses between a human alveolar type-I-like epithelial cell line, and primary human ATII epithelial cells and AMs from the same donor subjects, allows us to draw strong conclusions as to the lung-cell-specific pro-inflammatory response to MWCNTs of different lengths and furthermore, highlights the inadequacy of using a single cell model for nanomaterial safety screening.
